Navan's Kim Hamer talks about what travel buyers say they need now, why the end-to-end experience matters, performance of AI ...
Summit Therapeutics Inc. (NASDAQ: SMMT) today announced it has entered into a clinical trial collaboration with GSK plc ("GSK ...
Company expects preliminary unaudited AUCATZYL® net product revenue of approximately $24 million for the fourth quarter of 2025 and approximately $75 million for the full year of 2025Autolus anticipat ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback